Focal vs. Diffuse Patients: Comparing Outcomes
Published on
Researchers at CHOP’s HI Center conducted a study comparing the clinical features, treatments and short-term outcomes of children with HI who underwent pancreatectomies.
Published on
Researchers at CHOP’s HI Center conducted a study comparing the clinical features, treatments and short-term outcomes of children with HI who underwent pancreatectomies.
Published on
An infant with hyperinsulinism (HI) and Beckwith-Wiedemann syndrome (BWS) faces unique challenges with oral feeding.
Published on
CHOP has found that an investigational drug could point to the first potential medical treatment for children with a type of HI.
Published on
CHOP is investigating an alternative treatment for HI: a new drug that can help manage glucose levels in even the most severe forms of the disease — without surgery.
Published on
Naomi was finally diagnosed with diffuse congenital hyperinsulinism after nine months of improper treatment.
Published on
CHOP has found that an investigational drug could point to the first potential medical treatment for children with a type of HI.
Published on
There is no doubt that Oliver Fallon is one of the lucky ones — if you can call getting a rare disease like congenital hyperinsulinism (HI) lucky.